1 ）Aoyama T: Perioperative body composition changes in the multimodal treatment of gastrointestinal cancer. Surg Today‚ 50（3）: 217-222‚ 2020. doi: 10.1007/s00595-019- 01815-8. Epub 2019 Apr 26. PMID: 31028458.
2 ）Aoyama T‚ Yoshikawa T‚ Shirai J‚ Hayashi T‚ Ogata T‚ Cho H‚ Yukawa N‚ Oshima T‚ Rino Y‚ Ozawa Y‚ Kitani Y‚ Wada H‚ Masuda M‚ Tsuburaya A: ［Comparison of body weight loss in gastrectomy patients who underwent only surgery and those who underwent surgery followed up with S-1 adjuvant chemotherapy］. Gan To Kagaku Ryoho‚ 39（12）: 1794-1796‚ 2012. Japanese. PMID: 23267889.
3 ） Aoyama T‚ Kawabe T‚ Hirohito F‚ Hayashi T‚ Yamada T‚ Tsuchida K‚ Sato T‚ Oshima T‚ Rino Y‚ Masuda M‚ Ogata T‚ Cho H‚ Yoshikawa T: Body composition analysis within 1 month after gastrectomy for gastric cancer. Gastric Cancer‚ 19（2）: 645-650‚ 2016. doi: 10.1007/s10120-015-0496-x. Epub 2015 Apr 17. PMID: 25893261.
4 ） Jensen MB‚ Houborg KB‚ Nørager CB‚ Henriksen MG‚ Laurberg S: Postoperative changes in fatigue‚ physical function and body composition: an analysis of the amalgamated data from five randomized trials on patients undergoing colorectal surgery. Colorectal Dis‚ 13（5）: 588-593‚ 2011. doi: 10.1111/j.1463-1318.2010.02232.x. PMID: 20148922.
5 ） Prado CM‚ Baracos VE‚ McCargar LJ‚ Mourtzakis M‚ Mulder KE‚ Reiman T‚ Butts CA‚ Scarfe AG‚ Sawyer MB: Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res‚ 13（11）: 3264-3268‚ 2007. doi: 10.1158/1078-0432. CCR-06-3067. PMID: 17545532.
6 ） Prado CM‚ Baracos VE‚ McCargar LJ‚ Reiman T‚ Mourtzakis M‚ Tonkin K‚ Mackey JR‚ Koski S‚ Pituskin E‚ Sawyer MB: Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res‚ 15（8）: 2920-2926‚ 2009. doi: 10.1158/1078-0432.CCR08-2242. Epub 2009 Apr 7. PMID: 19351764.
7 ） Sakuramoto S‚ Sasako M‚ Yamaguchi T‚ Kinoshita T‚ Fujii M‚ Nashimoto A‚ Furukawa H‚ Nakajima T‚ Ohashi Y‚ Imamura H‚ Higashino M‚ Yamamura Y‚ Kurita A‚ Arai K: ACTS-GC Group: Adjuvant chemotherapy for gastric cancer with S-1‚ an oral fluoropyrimidine. N Engl J Med‚ 357（18）: 1810-1820‚ 2007. doi: 10.1056/NEJMoa072252. Erratum in: N Engl J Med‚ 358（18）: 1977‚ 2008. PMID: 17978289.
8 ） Bang YJ‚ Kim YW‚ Yang HK‚ Chung HC‚ Park YK‚ Lee KH‚ Lee KW‚ Kim YH‚ Noh SI‚ Cho JY‚ Mok YJ‚ Kim YH‚ Ji J‚ Yeh TS‚ Button P‚ Sirzén F‚ Noh SH: CLASSIC trial investigators. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy （CLASSIC）: a phase 3 open-label‚ randomised controlled trial. Lancet‚ 379（9813）: 315-321‚ 2012. doi: 10.1016/S0140-6736 （11）61873-4. Epub 2012 Jan 7. PMID: 22226517.
9 ） Yoshida K‚ Kodera Y‚ Kochi M‚ Ichikawa W‚ Kakeji Y‚ Sano T‚ Nagao N‚ Takahashi M‚ Takagane A‚ Watanabe T‚ Kaji M‚ Okitsu H‚ Nomura T‚ Matsui T‚ Yoshikawa T‚ Matsuyama J‚ Yamada M‚ Ito S‚ Takeuchi M‚ Fujii M: Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07‚ a Randomized Controlled Trial. J Clin Oncol‚ 37（15）: 1296-1304‚ 2019. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29. PMID: 30925125; PMCID: PMC6524985.
10） Aoyama T‚ Yoshikawa T‚ Shirai J‚ Hayashi T‚ Yamada T‚ Tsuchida K‚ Hasegawa S‚ Cho H‚ Yukawa N‚ Oshima T‚ Rino Y‚ Masuda M‚ Tsuburaya A: Body weight loss after surgery is an independent risk factor for continuation of S -1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol‚ 20（6）: 2000-2006‚ 2013. doi: 10.1245/s10434- 012-2776-6. Epub 2012 Dec 16. PMID: 23242818.
11） Aoyama T‚ Kawabe T‚ Fujikawa H‚ Hayashi T‚ Yamada T‚ Tsuchida K‚ Yukawa N‚ Oshima T‚ Rino Y‚ Masuda M‚ Ogata T‚ Cho H‚ Yoshikawa T: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol‚ 22（8）: 2560-2566‚ 2015. doi: 10.1245/s10434- 014-4296-z. Epub 2014 Dec 17. Erratum in: Ann Surg Oncol. 2015 Dec;22 Suppl 3: S1616. PMID: 25515199.
12） Awad S‚ Tan BH‚ Cui H‚ Bhalla A‚ Fearon KC‚ Parsons SL‚ Catton JA‚ Lobo DN: Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr‚ 31（1）: 74-77‚ 2012. doi: 10.1016/j.clnu.2011.08.008. Epub 2011 Aug 27. PMID: 21875767.
13）Yip C‚ Goh V‚ Davies A‚ Gossage J‚ Mitchell-Hay R‚ Hynes O‚ Maisey N‚ Ross P‚ Gaya A‚ Landau DB‚ Cook GJ‚ Griffin N‚ Mason R: Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer. Eur Radiol‚ 24（5）: 998-1005‚ 2014. doi: 10.1007/s00330-014-3110-4. Epub 2014 Feb 18. PMID: 24535076.
14） Lieffers JR‚ Bathe OF‚ Fassbender K‚ Winget M‚ Baracos VE: Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer‚ 107（6）: 931-936‚ 2012. doi: 10.1038/bjc.2012.350. Epub 2012 Aug 7. PMID: 22871883; PMCID: PMC3464761.
15） Aoyama T‚ Oba K‚ Honda M‚ Sadahiro S‚ Hamada C‚ Mayanagi S‚ Kanda M‚ Maeda H‚ Kashiwabara K‚ Sakamoto J‚ Saji S‚ Yoshikawa T: Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patientsʼ data from three large phase III randomized trials. Cancer Med‚ 6（7）: 1573-1580‚ 2017. doi: 10.1002/cam4.1126. Epub 2017 Jun 22. PMID: 28639738; PMCID: PMC5504309.
16） Aoyama T‚ Murakawa M‚ Katayama Y‚ Yamaoku K‚ Kanazawa A‚ Higuchi A‚ Shiozawa M‚ Morimoto M‚ Yoshikawa T‚ Yamamoto N‚ Rino Y‚ Masuda M‚ Morinaga S: Impact of postoperative complications on survival and recurrence in pancreatic cancer. Anticancer Res‚ 35（4）: 2401-2409‚ 2015. PMID: 25862906.
17） Antoun S‚ Baracos VE‚ Birdsell L‚ Escudier B‚ Sawyer MB: Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol‚ 21（8）: 1594-1598‚ 2010. doi: 10.1093/annonc/mdp605. Epub 2010 Jan 20. PMID: 20089558.
18） Huillard O‚ Mir O‚ Peyromaure M‚ Tlemsani C‚ Giroux J‚ Boudou-Rouquette P‚ Ropert S‚ Delongchamps NB‚ Zerbib M‚ Goldwasser F: Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients. Br J Cancer‚ 108（5）: 1034-1041‚ 2013. doi: 10.1038/bjc.2013.58. Epub 2013 Mar 5. PMID: 23462722; PMCID: PMC3619075.
19） Aoyama T‚ Nakazono M‚ Nagasawa S‚ Segami K: Clinical Impact of a Perioperative Exercise Program for Sarcopenia and Overweight/Obesity Gastric Cancer. In Vivo‚ 35（2）: 707-712‚ 2021. doi: 10.21873/invivo.12311. PMID: 33622863; PMCID: PMC8045110.
20） Aoyama T‚ Nakazono M‚ Nagasawa S‚ Segami K: Clinical Impact of Perioperative Oral Nutritional Treatment for Body Composition Changes in Gastrointestinal Cancer Treatment. Anticancer Res‚ 41（4）: 1727-1732‚ 2021. doi: 10.21873/anticanres.14937. PMID: 33813376.
21） Ryan AM‚ Reynolds JV‚ Healy L‚ Byrne M‚ Moore J‚ Brannelly N‚ McHugh A‚ McCormack D‚ Flood P: Enteral nutrition enriched with eicosapentaenoic acid （EPA） preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg‚ 249（3）: 355-363‚ 2009. doi: 10.1097/SLA.0b013e31819a4789. PMID: 19247018.
22） Ida S‚ Hiki N‚ Cho H‚ Sakamaki K‚ Ito S‚ Fujitani K‚ Takiguchi N‚ Kawashima Y‚ Nishikawa K‚ Sasako M‚ Aoyama T‚ Honda M‚ Sato T‚ Nunobe S‚ Yoshikawa T: Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer. Br J Surg‚ 104（4）: 377-383‚ 2017. doi: 10.1002/bjs.10417. Epub 2017 Jan 10. PMID: 28072447.
23） Aoyama T‚ Yoshikawa T‚ Ida S‚ Cho H‚ Sakamaki K‚ Ito Y‚ Fujitani K‚ Takiguchi N‚ Kawashima Y‚ Nishikawa K‚ Oshima T‚ Nunobe S‚ Hiki N: Effects of perioperative Eicosapentaenoic acid-enriched oral nutritional supplement on lean body mass after total gastrectomy for gastric cancer. J Cancer‚ 10（5）: 1070-1076‚ 2019. doi: 10.7150/ jca.29632. PMID: 30854113; PMCID: PMC6400678.
24） Healy LA‚ Ryan A‚ Doyle SL‚ Ní Bhuachalla ÉB‚ Cushen S‚ Segurado R‚ Murphy T‚ Ravi N‚ Donohoe CL‚ Reynolds JV: Does Prolonged Enteral Feeding With Supplemental Omega-3 Fatty Acids Impact on Recovery Post-esophagectomy: Results of a Randomized DoubleBlind Trial. Ann Surg‚ 266（5）: 720-728‚ 2017. doi: 10.1097/SLA.0000000000002390. PMID: 28742713.
25） Aoyama T‚ Yoshikawa T‚ Hayashi T‚ Hasegawa S‚ Tsuchida K‚ Yamada T‚ Cho H‚ Ogata T‚ Fujikawa H‚ Yukawa N‚ Oshima T‚ Rino Y‚ Masuda M: Randomized comparison of surgical stress and the nutritional status between laparoscopy-assisted and open distal gastrectomy for gastric cancer. Ann Surg Oncol‚ 21（6）: 1983-1990‚ 2014. doi: 10.1245/s10434-014-3509-9. Epub 2014 Feb 6. PMID: 24499830.
26） Aoyama T‚ Sato T‚ Hayashi T‚ Yamada T‚ Cho H‚ Ogata T‚ Oba K‚ Yoshikawa T: Does a laparoscopic approach attenuate the body weight loss and lean body mass loss observed in open distal gastrectomy for gastric cancer？ a single-institution exploratory analysis of the JCOG 0912 phase III trial. Gastric Cancer‚ 21（2）: 345-352‚ 2018. doi: 10.1007/s10120-017-0735-4. Epub 2017 Jun 16. PMID: 28623524.
27） Adachi Y‚ Shiraishi N‚ Shiromizu A‚ Bandoh T‚ Aramaki M‚ Kitano S: Laparoscopy-assisted Billroth I gastrectomy compared with conventional open gastrectomy. Arch Surg‚ 135（7）: 806-810‚ 2000. doi: 10.1001/archsurg. 135.7.806. PMID: 10896374.
28） Yamamoto K‚ Nagatsuma Y‚ Fukuda Y‚ Hirao M‚ Nishikawa K‚ Miyamoto A‚ Ikeda M‚ Nakamori S‚ Sekimoto M‚ Fujitani K‚ Tsujinaka T: Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer. Gastric Cancer‚ 20（5）: 913-918‚ 2017. doi: 10.1007/s10120-016 -0683-4. Epub 2016 Dec 28. PMID: 28032232.
29） Cho I‚ Son Y‚ Song S‚ Bae YJ‚ Kim YN‚ Kim HI‚ Lee DT‚ Hyung WJ: Feasibility and Effects of a Postoperative Recovery Exercise Program Developed Specifically for Gastric Cancer Patients （PREP-GC） Undergoing Minimally Invasive Gastrectomy. J Gastric Cancer‚ 18 （2）: 118-133‚ 2018. doi: 10.5230/jgc.2018.18.e12. Epub 2018 Apr 25. PMID: 29984062; PMCID: PMC6026706.
30） Cho H‚ Yoshikawa T‚ Oba MS‚ Hirabayashi N‚ Shirai J‚ Aoyama T‚ Hayashi T‚ Yamada T‚ Oba K‚ Morita S‚ Sakamoto J‚ Tsuburaya A: Matched pair analysis to examine the effects of a planned preoperative exercise program in early gastric cancer patients with metabolic syndrome to reduce operative risk: the Adjuvant Exercise for General Elective Surgery （AEGES） study group. Ann Surg Oncol‚ 21（6）: 2044-2050‚ 2014. doi: 10.1245/ s10434-013-3394-7. Epub 2014 Mar 27. PMID: 24671637.
31） Hatao F‚ Chen KY‚ Wu JM‚ Wang MY‚ Aikou S‚ Onoyama H‚ Shimizu N‚ Fukatsu K‚ Seto Y‚ Lin MT: Randomized controlled clinical trial assessing the effects of oral nutritional supplements in postoperative gastric cancer patients. Langenbecks Arch Surg‚ 402（2）: 203-211‚ 2017. doi: 10.1007/s00423-016-1527-8. Epub 2016 Nov 2. PMID: 27807617.
32） Imamura H‚ Nishikawa K‚ Kishi K‚ Inoue K‚ Matsuyama J‚ Akamaru Y‚ Kimura Y‚ Tamura S‚ Kawabata R‚ Kawada J‚ Fujiwara Y‚ Kawase T‚ Fukui J‚ Takagi M‚ Takeno A‚ Shimokawa T: Effects of an Oral Elemental Nutritional Supplement on Post-gastrectomy Body Weight Loss in Gastric Cancer Patients: A Randomized Controlled Clinical Trial. Ann Surg Oncol‚ 23（9）: 2928-2935‚ 2016. doi: 10.1245/s10434-016-5221-4. Epub 2016 Apr 15. PMID: 27084538.
33） Kong SH‚ Lee HJ‚ Na JR‚ Kim WG‚ Han DS‚ Park SH‚ Hong H‚ Choi Y‚ Ahn HS‚ Suh YS‚ Yang HK: Effect of perioperative oral nutritional supplementation in malnourished patients who undergo gastrectomy: A prospective randomized trial. Surgery‚ 164（6）: 1263- 1270‚ 2018. doi: 10.1016/j.surg.2018.05.017. Epub 2018 Jul 25. PMID: 30055788.
34） Aoyama T‚ Sato T‚ Segami K‚ Maezawa Y‚ Kano K‚ Kawabe T‚ Fujikawa H‚ Hayashi T‚ Yamada T‚ Tsuchida K‚ Yukawa N‚ Oshima T‚ Rino Y‚ Masuda M‚ Ogata T‚ Cho H‚ Yoshikawa T: Risk Factors for the Loss of Lean Body Mass After Gastrectomy for Gastric Cancer. Ann Surg Oncol‚ 23（6）: 1963-1970‚ 2016. doi: 10.1245/s10434- 015-5080-4. Epub 2016 Jan 13. PMID: 26762272.
35） Segami K‚ Aoyama T‚ Kano K‚ Maezawa Y‚ Nakajima T‚ Ikeda K‚ Sato T‚ Fujikawa H‚ Hayashi T‚ Yamada T‚ Oshima T‚ Yukawa N‚ Rino Y‚ Masuda M‚ Ogata T‚ Cho H‚ Yoshikawa T: Risk factors for severe weight loss at 1 month after gastrectomy for gastric cancer. Asian J Surg‚ 41（4）: 349-355‚ 2018. doi: 10.1016/j.asjsur.2017.02.005. Epub 2017 May 22. PMID: 28545783.
論文の公開元へ
